Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ultrasound-guided Versus Arthroscopic Guided PRF Injection for TMJ Disc Displacement.

NCT: NCT07535073 · NOT_YET_RECRUITING

NCT IDNCT07535073
StatusNOT_YET_RECRUITING
Start Date2026-05-07
Completion2027-06-07

Brief Summary

To compare the clinical effectiveness of ultrasound-guided versus arthroscopic guided platelet rich fibrin injection in the management of anterior disc displacement with reduction of the temporomandibular joint, in terms of pain reduction, improvement of mandibular function, and patient-reported outcomes.

Frequently Asked Questions

What is Ultrasound-guided Versus Arthroscopic Guided PRF Injection for TMJ Disc Displacement.?

Ultrasound-guided Versus Arthroscopic Guided PRF Injection for TMJ Disc Displacement. is a clinical trial registered under NCT07535073. Current status: NOT_YET_RECRUITING.

What is the status of NCT07535073?

The current status of NCT07535073 (Ultrasound-guided Versus Arthroscopic Guided PRF Injection for TMJ Disc Displacement.) is: NOT_YET_RECRUITING.

When did Ultrasound-guided Versus Arthroscopic Guided PRF Injection for TMJ Disc Displacement. start?

Ultrasound-guided Versus Arthroscopic Guided PRF Injection for TMJ Disc Displacement. started on 2026-05-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑